ITP Education Kit

Learn more about ITP and WinRho when you order the ITP Educational Resource Kit
educational patient kit

ITP Juego Educativo

Aprenda más acercade ITP
y WinRho cuando usted ordena el ITP Juego Educativo de Recurso

Duration of Response

Response duration varies according to treatment groups, but has been shown to reach almost 90 days in adults with chronic ITP.1,2

* Study was performed using WinRho/WinRho SD
† Dose = 20-75 µg/kg (100-375 IU/kg); Response = platelet increase to ≥20,000/mm3

WinRho SDF Liquid is Bioequivalent to WinRho SDF Lyophilized

In two comparative pharmacokinetic studies (n=101), the formulations were bioequivalent following IV administration based on area under the curve to 84 days and had comparable pharmacokinetics following IM administration. Both formulations also had similiar elimination half-lives. WinRho®  SDF must be administered via the intravenous route for the treatment of ITP.

Please see Important Safety Information and Prescribing Information.

  1. WinRho® SDF [Rho(D) Immune Globulin Intravenous (Human)] package insert, Cangene Corporation,Winnipeg, Canada. Baxter Healthcare Corporation,WestlakeVillage, CA, USA, April 2006.
  2. Data on file, Cangene Corporation, Baxter Healthcare Corporation.